Meghan Hattarki

1.4k citations

26 papers · 788 indexed · h-index 17

Radiology, Nuclear Medicine and Imaging top 5%
- Monoclonal and Polyclonal Antibodies Research 12
Molecular Biology
- Glycosylation and Glycoproteins Research 5
- Biochemical and Molecular Research 5
- Advanced biosensing and bioanalysis techniques 2
- Protein purification and stability 2
Immunology
Immunology and Allergy
Pharmacology
Epidemiology
- Pneumocystis jirovecii pneumonia detection and treatment 4
Infectious Diseases
- HIV/AIDS drug development and treatment 4
Physiology
- Alzheimer's disease research and treatments 3

Co-authors: Stewart D. Nuttall Peter J. Hudson Robert A. Irving Larissa Doughty Olan Dolezal Davide Gori Jennifer A. Carmichael Alexander A. Kortt
Cited by: Radiology, Nuclear Medicine and Imaging Molecular Biology Immunology
Journals: PLoS ONE (1 paper)Analytical Biochemistry (1 paper)Journal of Medicinal Chemistry (1 paper)
Partner nations: Australia United Kingdom China

In The Last Decade

Meghan Hattarki

26 papers receiving 756 citations

Peers

Countries citing papers authored by Meghan Hattarki

Since Specialization

Citations

This map shows the geographic impact of Meghan Hattarki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meghan Hattarki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meghan Hattarki more than expected).

Fields of papers citing papers by Meghan Hattarki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meghan Hattarki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meghan Hattarki. The network helps show where Meghan Hattarki may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Meghan Hattarki, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Meghan Hattarki Line = papers co-authored together Meghan Hattarki links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Crystal structures of human ENPP1 in apo and bound forms Acta Crystallographica Section D Structural Biology ·Matthew L. Dennis,Janet Newman,Olan Dolezal,Meghan Hattarki,Regina Surjadi,Stewart D. Nuttall,Tam Pham,Thomas Nebl,Michelle A. Camerino,Poh Sim Khoo,Brendon J. Monahan,Thomas S. Peat	2020	26
2	Structure-Based Design and Development of Functionalized Mercaptoguanine Derivatives as Inhibitors of the Folate Biosynthesis Pathway Enzyme 6-Hydroxymethyl-7,8-dihydropterin Pyrophosphokinase from Staphylococcus aureus Journal of Medicinal Chemistry ·Matthew L. Dennis,Sandeep Chhabra,Zhong‐Chang Wang,Aaron DeBono,Olan Dolezal,Janet Newman,Noel P. Pitcher,Raphaël Rahmani,Ben Cleary,Νicholas Barlow,Meghan Hattarki,Bim Graham,Thomas S. Peat,Jonathan B. Baell,James Swarbrick	2014	13
3	Fragment Screening for the Modelling Community: SPR, ITC, and Crystallography Australian Journal of Chemistry ·Olan Dolezal,Larissa Doughty,Meghan Hattarki,Vincent Fazio,Tom T. Caradoc-Davies,Janet Newman,Thomas S. Peat	2013	6
4	Fragment Screening on Staphylococcus aureus HPPK – a Folate Pathway Target Australian Journal of Chemistry ·Sandeep Chhabra,Olan Dolezal,Meghan Hattarki,Thomas S. Peat,Jamie S. Simpson,James Swarbrick	2013	4
5	Central amyloid- -specific single chain variable fragment ameliorates A aggregation and neurotoxicity Protein Engineering Design and Selection ·Rebecca M. Nisbet,Julie Nigro,Kerry Breheney,Joanne M. Caine,Meghan Hattarki,Stewart D. Nuttall	2013	16
6	Exploring the Chemical Space around 8-Mercaptoguanine as a Route to New Inhibitors of the Folate Biosynthesis Enzyme HPPK PLoS ONE ·Sandeep Chhabra,Νicholas Barlow,Olan Dolezal,Meghan Hattarki,Janet Newman,Thomas S. Peat,Bim Graham,James Swarbrick	2013	15
7	An Efficient High-Throughput Screening Method for MYST Family Acetyltransferases, a New Class of Epigenetic Drug Targets SLAS DISCOVERY ·Hendrik Falk,Theresa Connor,Hong Yang,Karen J. Loft,Joanne L. Alcindor,George Nikolakopoulos,Regina Surjadi,John D. Bentley,Meghan Hattarki,Olan Dolezal,James M. Murphy,Brendon J. Monahan,Thomas S. Peat,Tim Thomas,Jonathan B. Baell,John P. Parisot,Ian P. Street	2011	35
8	Engineered antibody intervention strategies for Alzheimer's disease and related dementias by targeting amyloid and toxic oligomers Protein Engineering Design and Selection ·R. Robert,Olan Dolezal,Lynne J. Waddington,Meghan Hattarki,Roberto Cappai,Colin L. Masters,Peter J. Hudson,Kailee Wark	2008	42
9	Kinetic screening of antibody–Im7 conjugates by capture on a colicin E7 DNase domain using optical biosensors Analytical Biochemistry ·Ralf J. Hosse,Leigh Tay,Meghan Hattarki,Luisa Pontes‐Braz,Lesley A. Pearce,Stewart D. Nuttall,Olan Dolezal	2008	19
10	Dimerisation strategies for shark IgNAR single domain antibody fragments Journal of Immunological Methods ·David P. Simmons,Fiona A. Abregu,Usha V. Krishnan,David F. Proll,Victor A. Streltsov,Larissa Doughty,Meghan Hattarki,Stewart D. Nuttall	2006	39
11	Engineering of the Escherichia coli Im7 immunity protein as a loop display scaffold Protein Engineering Design and Selection ·Suzy M. Juraja,Terrence D. Mulhern,Peter J. Hudson,Meghan Hattarki,Jennifer A. Carmichael,Stewart D. Nuttall	2006	16
12	Selection and affinity maturation of IgNAR variable domains targeting Plasmodium falciparum AMA1 Proteins Structure Function and Bioinformatics ·Stewart D. Nuttall,Karen S. Humberstone,Usha V. Krishnan,Jennifer A. Carmichael,Larissa Doughty,Meghan Hattarki,Andrew M. Coley,Joanne L. Casey,Robin F. Anders,Michael Foley,Robert A. Irving,Peter J. Hudson	2004	88
13	Cytotoxic properties of immunoconjugates containing melittin-like peptide 101 against prostate cancer: in vitro and in vivo studies Cancer Immunology Immunotherapy ·Pamela J. Russell,Dean R. Hewish,Teresa Carter,Katy Sterling-Levis,Kim Ow,Meghan Hattarki,Larissa Doughty,Robin E. Guthrie,Deborah Shapira,Peter L. Molloy,Jerome A. Werkmeister,Alexander A. Kortt	2004	74
14	Biodistributions of intact monoclonal antibodies and fragments of BLCA-38, a new prostate cancer directed antibody Cancer Immunology Immunotherapy ·Teresa Carter,Katy Sterling-Levis,Kim Ow,Larissa Doughty,Meghan Hattarki,Deborah Shapira,Dean R. Hewish,Alexander A. Kortt,Pamela J. Russell	2004	18
15	Single-chain Fv multimers of the anti-neuraminidase antibody NC10: the residue at position 15 in the VL domain of the scFv-0 (VL−VH) molecule is primarily responsible for formation of a tetramer–trimer equilibrium Protein Engineering Design and Selection ·Olan Dolezal,Davide Gori,Mark Walter,Larissa Doughty,Meghan Hattarki,Peter J. Hudson,Alexander A. Kortt	2003	29
16	Isolation and characterization of an IgNAR variable domain specific for the human mitochondrial translocase receptor Tom70 European Journal of Biochemistry ·Stewart D. Nuttall,Usha V. Krishnan,Larissa Doughty,Kylie Pearson,Michael T. Ryan,Nicholas J. Hoogenraad,Meghan Hattarki,Jennifer A. Carmichael,Robert A. Irving,Peter J. Hudson	2003	59
17	Construction, expression and characterisation of a single-chain diabody derived from a humanised anti-Lewis Y cancer targeting antibody using a heat-inducible bacterial secretion vector Cancer Immunology Immunotherapy ·Barbara Power,Joanne M. Caine,John E. Burns,Deborah Shapira,Meghan Hattarki,Kiki Tahtis,F.-T. Lee,Fiona E. Smyth,Andrew M. Scott,Alexander A. Kortt,Peter J. Hudson	2001	26
18	Isolation of the new antigen receptor from wobbegong sharks, and use as a scaffold for the display of protein loop libraries Molecular Immunology ·Stewart D. Nuttall,Usha V. Krishnan,Meghan Hattarki,Davide Gori,Robert A. Irving,Peter J. Hudson	2001	122
19	Inactivation and Clearance of Viruses During the Manufacture of High Purity Factor IX Biologicals ·Anna Johnston,A. MacGregor,Steven Borovec,Meghan Hattarki,Keith G Stuckly,David A. Anderson,Neil H. Goss,A. Oates,Eric Uren	2000	19
20	Chromatographic removal and heat inactivation of hepatitis A virus during manufacture of human albumin Biotechnology and Applied Biochemistry ·Wayne Adcock,A. MacGregor,Jeff R. Davies,Meghan Hattarki,David A. Anderson,Neil H. Goss	1998	31

About Meghan Hattarki

Meghan Hattarki is a scholar working on Radiology, Nuclear Medicine and Imaging, Immunology and Allergy and Infectious Diseases, having authored 26 papers that have together received 788 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (12 papers), Glycosylation and Glycoproteins Research (5 papers), Biochemical and Molecular Research (5 papers), Pneumocystis jirovecii pneumonia detection and treatment (4 papers), HIV/AIDS drug development and treatment (4 papers), Alzheimer's disease research and treatments (3 papers), Advanced biosensing and bioanalysis techniques (2 papers) and Protein purification and stability (2 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (378 citations), Molecular Biology (500 citations) and Immunology (131 citations). Meghan Hattarki has collaborated with scholars based in Australia, United Kingdom and China. Frequent co-authors include Stewart D. Nuttall, Peter J. Hudson, Robert A. Irving, Larissa Doughty, Olan Dolezal, Davide Gori, Jennifer A. Carmichael, Alexander A. Kortt, Thomas S. Peat and David A. Anderson. Their work appears in journals such as PLoS ONE, Analytical Biochemistry and Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact